What is the oral dose of Bumex (bumetanide)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Oral Dosage of Bumetanide (Bumex)

The standard oral dose of bumetanide (Bumex) is 0.5 to 1.0 mg once or twice daily, with a maximum total daily dose of 10 mg. 1

Dosing Guidelines

  • Initial oral dosing typically starts at 0.5 to 1.0 mg once or twice daily 1
  • Due to bumetanide's short duration of action (4-6 hours per dose), multiple daily dosing may be necessary to maintain diuresis throughout the day 1
  • The total daily dose should not exceed 10 mg, regardless of dosing frequency 1
  • Bumetanide is approximately 40 times more potent than furosemide on a milligram-for-milligram basis 2, 3

Pharmacokinetic Properties

  • Bumetanide is rapidly absorbed after oral administration, with peak plasma levels achieved approximately 30 minutes after dosing 3
  • The drug has a short half-life of 1.2-1.5 hours 3
  • Duration of action is typically 3-6 hours per dose 2
  • The principal site of action is the ascending limb of the loop of Henle, with a secondary action on the proximal tubule 2

Clinical Applications

  • For heart failure patients, bumetanide can be administered up to three times daily when clinically indicated 1
  • In patients with severe fluid overload requiring sustained diuresis, three-times-daily dosing may be particularly useful 1
  • For patients with refractory edema who need more frequent dosing to maintain diuretic effect, multiple daily doses may be necessary 1
  • Higher doses (up to 15 mg/day) may be required in patients with chronic renal failure or nephrotic syndrome 2

Monitoring and Precautions

  • More frequent dosing requires careful monitoring for electrolyte disturbances, particularly hypokalemia and hyponatremia 1
  • Careful monitoring for volume depletion and prerenal azotemia is necessary with multiple daily dosing 1
  • When initiating a three-times-daily regimen, start with lower doses (e.g., 0.5-1 mg per dose) 1
  • Titrate based on clinical response, monitoring urine output and symptoms of congestion 1

Special Considerations

  • For elderly patients, dose reduction may be necessary 1
  • In patients with renal insufficiency, dose adjustments may be required based on creatinine clearance 1
  • Combination with thiazide diuretics may enhance the clinical response to bumetanide in cases of diuretic resistance 1, 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.